AIMS/HYPOTHESIS: Inflammation in obesity increases the levels of the suppressor of cytokine signalling-3 (SOCS3) protein in adipose tissue, but the physiological importance of this protein in regulating whole-body insulin sensitivity in obesity is not known. METHODS: We generated Socs3 floxed (wild-type, WT) and Socs3 aP2 (also known as Fabp4)-Cre null (Socs3 AKO) mice. Mice were maintained on either a regular chow or a high-fat diet (HFD) for 16 weeks during which time body mass, adiposity, glucose homeostasis and insulin sensitivity were assessed. RESULTS: The HFD increased SOCS3 levels in adipose tissue of WT but not Socs3 AKO mice. WT and Socs3 AKO mice had similar body mass and adiposity, assessed using computed tomography (CT) imaging, irrespective of diet or sex. On a control chow diet there were no differences in insulin sensitivity or glucose tolerance. When fed a HFD, female but not male Socs3 AKO mice had improved glucose tolerance as well as lower fasting glucose and insulin levels compared with WT littermates. Hyperinsulinaemic-euglycaemic clamps and positron emission tomography (PET) imaging demonstrated that improved insulin sensitivity was due to elevated adipose tissue glucose uptake. Increased insulin-stimulated glucose uptake in adipose tissue was associated with enhanced levels and activating phosphorylation of insulin receptor substrate-1 (IRS1). CONCLUSIONS/ INTERPRETATION: These data demonstrate that inhibiting SOCS3 production in adipose tissue of female mice is effective for improving whole-body insulin sensitivity in obesity.
AIMS/HYPOTHESIS: Inflammation in obesity increases the levels of the suppressor of cytokine signalling-3 (SOCS3) protein in adipose tissue, but the physiological importance of this protein in regulating whole-body insulin sensitivity in obesity is not known. METHODS: We generated Socs3 floxed (wild-type, WT) and Socs3 aP2 (also known as Fabp4)-Cre null (Socs3 AKO) mice. Mice were maintained on either a regular chow or a high-fat diet (HFD) for 16 weeks during which time body mass, adiposity, glucose homeostasis and insulin sensitivity were assessed. RESULTS: The HFD increased SOCS3 levels in adipose tissue of WT but not Socs3 AKO mice. WT and Socs3 AKO mice had similar body mass and adiposity, assessed using computed tomography (CT) imaging, irrespective of diet or sex. On a control chow diet there were no differences in insulin sensitivity or glucose tolerance. When fed a HFD, female but not male Socs3 AKO mice had improved glucose tolerance as well as lower fasting glucose and insulin levels compared with WT littermates. Hyperinsulinaemic-euglycaemic clamps and positron emission tomography (PET) imaging demonstrated that improved insulin sensitivity was due to elevated adipose tissue glucose uptake. Increased insulin-stimulated glucose uptake in adipose tissue was associated with enhanced levels and activating phosphorylation of insulin receptor substrate-1 (IRS1). CONCLUSIONS/ INTERPRETATION: These data demonstrate that inhibiting SOCS3 production in adipose tissue of female mice is effective for improving whole-body insulin sensitivity in obesity.
Authors: Emma Jamieson; Mark M W Chong; Gregory R Steinberg; Valentina Jovanovska; Barbara C Fam; Denise V R Bullen; Ye Chen; Bruce E Kemp; Joseph Proietto; Thomas W H Kay; Sofianos Andrikopoulos Journal: J Biol Chem Date: 2005-06-27 Impact factor: 5.157
Authors: B Emanuelli; P Peraldi; C Filloux; C Chavey; K Freidinger; D J Hilton; G S Hotamisligil; E Van Obberghen Journal: J Biol Chem Date: 2001-10-16 Impact factor: 5.157
Authors: Gary M Leong; Sofia Moverare; Jesena Brce; Nathan Doyle; Klara Sjögren; Karin Dahlman-Wright; Jan-Ake Gustafsson; Ken K Y Ho; Claes Ohlsson; Kin-Chuen Leung Journal: Endocrinology Date: 2004-08-19 Impact factor: 4.736
Authors: Hiu Kiu; Christopher J Greenhalgh; Anne Thaus; Douglas J Hilton; Nicos A Nicola; Warren S Alexander; Andrew W Roberts Journal: Growth Factors Date: 2009-12 Impact factor: 2.511
Authors: Marie Björnholm; Heike Münzberg; Rebecca L Leshan; Eneida C Villanueva; Sarah H Bates; Gwendolyn W Louis; Justin C Jones; Ryoko Ishida-Takahashi; Christian Bjørbaek; Martin G Myers Journal: J Clin Invest Date: 2007-04-05 Impact factor: 14.808
Authors: Husam Ghanim; Sanaa Abuaysheh; Ching Ling Sia; Kelly Korzeniewski; Ajay Chaudhuri; Jose Manuel Fernandez-Real; Paresh Dandona Journal: Diabetes Care Date: 2009-09-15 Impact factor: 17.152
Authors: Alison S Reed; Elizabeth K Unger; Louise E Olofsson; Merisa L Piper; Martin G Myers; Allison W Xu Journal: Diabetes Date: 2010-01-12 Impact factor: 9.461
Authors: Laura Castellani; Jared Root-Mccaig; Scott Frendo-Cumbo; Marie-Soleil Beaudoin; David C Wright Journal: J Appl Physiol (1985) Date: 2014-03-27
Authors: Kimbell L Hetzler; Justin P Hardee; Holly A LaVoie; E Angela Murphy; James A Carson Journal: Am J Physiol Endocrinol Metab Date: 2017-03-14 Impact factor: 4.310
Authors: Laura Zemany; Bettina J Kraus; Julie Norseen; Tsugumichi Saito; Odile D Peroni; Randy L Johnson; Barbara B Kahn Journal: Mol Cell Biol Date: 2014-01-13 Impact factor: 4.272
Authors: Saul J Priceman; Maciej Kujawski; Shudan Shen; Gregory A Cherryholmes; Heehyoung Lee; Chunyan Zhang; Laura Kruper; Joanne Mortimer; Richard Jove; Arthur D Riggs; Hua Yu Journal: Proc Natl Acad Sci U S A Date: 2013-07-22 Impact factor: 11.205
Authors: Darlene E Berryman; Ellen R Lubbers; Vishakha Magon; Edward O List; John J Kopchick Journal: J Gerontol A Biol Sci Med Sci Date: 2013-05-21 Impact factor: 6.053
Authors: Hayley M O'Neill; James S Lally; Sandra Galic; Melissa Thomas; Paymon D Azizi; Morgan D Fullerton; Brennan K Smith; Thomas Pulinilkunnil; Zhiping Chen; M Constantine Samaan; Sebastian B Jorgensen; Jason R B Dyck; Graham P Holloway; Thomas J Hawke; Bryce J van Denderen; Bruce E Kemp; Gregory R Steinberg Journal: Diabetologia Date: 2014-06-10 Impact factor: 10.122